Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by James D. Young
Chimeric Constructs Between Human and Rat Equilibrative Nucleoside Transporters (hENT1 and rENT1) Reveal hENT1 Structural Domains Interacting With Coronary Vasoactive Drugs
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
Current Cancer Drug Targets
Cancer Research
Drug Discovery
Oncology
Pharmacology
The Human Equilibrative Nucleoside Transporter Protein1 (Hent1) Is a Predict /Prognostic Factor in Resected Pancreatic Cancer Patients
Biomedical Journal of Scientific & Technical Research
Mutation of Trp29of Human Equilibrative Nucleoside Transporter 1 Alters Affinity for Coronary Vasodilator Drugs and Nucleoside Selectivity
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Mutation of Leucine-92 Selectively Reduces the Apparent Affinity of Inosine, Guanosine, NBMPR [S6-(4-Nitrobenzyl)-Mercaptopurine Riboside] and Dilazep for the Human Equilibrative Nucleoside Transporter, hENT1
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Genomic Analysis of Nucleoside Transporters in Diptera and Functional Characterization ofDmENT2, a Drosophila Equilibrative Nucleoside Transporter
Physiological Genomics
Genetics
Physiology
Identification of Structural and Molecular Features Involved in the Transport of 3'-Deoxy-Nucleoside Analogs by Human Equilibrative Nucleoside Transporter 3
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Expression and Functional Activity of Nucleoside Transporters in Human Choroid Plexus
Cerebrospinal Fluid Research
Arginine Starvation and Docetaxel Induce C-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors
Clinical Cancer Research
Cancer Research
Oncology
Chimeric Proteins Containing MAP-1 and Functional Domains of C4b-Binding Protein Reveal Strong Complement Inhibitory Capacities
Molecular Immunology
Immunology
Molecular Biology